EBG MedAustron GmbH
Wiener Neustadt, Lower Austria, 2700, Austria
Location status: Recruiting
Location contact
Piero Fossati, MD MSc
CONTACT
+43 2622 26 100 ext. 408
Yvonne Goy, MD
CONTACT
+43 2622 26 100 ext. 407
Recruiting
NCT Number: NCT03049072
Ion Therapy Patient Registry
The purpose of the study is the prospective and standardized data collection of patients treated with ion therapy at MedAustron.
Recruiting
Interested in participating?
Request InfoKey information
Sex eligibility
All sexes
Study type
Observational
Primary location
About this study
During and up to 10 years after radiation therapy data regarding tumor control and treatment response as well as acute and late toxicities will be collected at regular time intervals. Additionally quality of life and sociodemographic status will be assessed in all study patients and neurocognitive assessment will be performed in patients undergoing ion radiation of the brain.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patients with tumor disease treated with ion beam therapy at MedAustron
- Signed informed consent form
Exclusion criteria
- Comorbidities endangering treatment delivery or study compliance
Treatment and study plan
Protons and Carbon Ions
RadiationPrimary outcomes
-
Therapy response
Time frame: 10 years
Therapy Response according to RECIST Version 1.1
-
Overall survival
Time frame: 10 years
-
Progression-free survival
Time frame: 10 years
-
Local progression-free survival
Time frame: 10 years
-
Cause-specific survival
Time frame: 10 years
-
Toxicity according to NCI CTCAE
Time frame: 10 years
Acute/late toxicity according to CTCAEv4.03, June 14,2010
Secondary outcomes
-
EORTC-QLQ-C30
Time frame: Through study completion, at 3, 5, and 10 years
Patient-reported quality of life
-
EORTC-QLQ-BN20
Time frame: Through study completion, at 3, 5, and 10 years
Patient-reported quality of life for brain cancer patients
-
EORTC-QLQ-PR25
Time frame: Through study completion, at 3, 5, and 10 years
Patient-reported quality of life for prostate cancer patients
-
Neurocognitive test battery
Time frame: Through study completion, at 3, 5, and 10 years
Change in cognition from baseline to endpoint as measured by standardized subtests of test battery
Study contacts
Contact information is provided by the study sponsor or research team.
Piero Fossati, MD MSc
CONTACT
+43 2622 26 100 ext. 408
Yvonne Goy, MD
CONTACT
+43 2622 26 100 ext. 407
Sponsors and collaborators
Lead sponsor
EBG MedAustron GmbH
Industry
Registry information
Official study title
A Prospective Registry Study to Record Clinical Results and Side Effects of Ion Beam Therapy at MedAustron
Acronym: REGI-MA-002015
Important dates
- Study start
- 2016
- Primary completion
- 2031
- Study completion
- 2036
- First posted
- Feb 9, 2017
- Registry last updated
- Mar 23, 2026
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.